German oncology centers determine Stage 3 liver cancer plans through mandatory multidisciplinary tumor boards. These panels combine expertise from hepatobiliary surgeons, interventional radiologists, and oncologists. Plans follow strict German Cancer Society (DKG) guidelines. Each recommendation prioritizes patient safety and liver function scores.
- Tumor board review: Specialists must reach a consensus before finalizing any surgical or medical roadmap.
- Functional staging: Doctors use Barcelona Clinic Liver Cancer (BCLC) criteria to assess surgical tolerance.
- Specialized mapping: High-resolution CT and MRI scans confirm vascular invasion or multiple nodules.
- Targeted pathways: Protocols include transarterial chemoembolization (TACE) or advanced systemic immunotherapy combinations.
Bookimed Expert Insight: German clinics like Nordrhein-Westfalen and Charité Berlin manage over 145,000 and 800,000 patients annually. This high volume allows doctors like Dr. Thomas W Kraus to perform over 3,000 surgeries. Data shows that larger academic centers offer wider access to specialized liver tumor boards. These boards frequently adjust initial diagnoses once interventional radiologists review the imaging discs.
Patient Consensus: Patients note that the final treatment plan often differs from the first doctor's suggestion. Many emphasize bringing actual imaging discs to ensure the tumor board has complete data.